TRASTUZUMAB MAFODOTIN
UNII FWA9E3VB3K

Substance Identification & Data

This profile provides standardized clinical and technical data for Trastuzumab Mafodotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FWA9E3VB3K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FWA9E3VB3K
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TRASTUZUMAB MAFODOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Trastuzumab Mafodotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LCB-14
LCB14-0110
TRASTUZUMAB MAFODOTIN
TRASTUZUMAB MAFODOTIN [WHO-DD]
TRASTUZUMAB MONOMETHYL AURISTATIN F

Technical Codes

FS-1502
IKS-014